Lilly to close Singapore R&D unit; double sales force in emerging markets
Eli Lilly has unveiled plans to close its Singapore R&D centre by the end of the year and relocate discovery operations to its global headquarters in the US.
Eli Lilly has unveiled plans to close its Singapore R&D centre by the end of the year and relocate discovery operations to its global headquarters in the US.
Particle Sciences (PSI) becomes provider of Solumer drug delivery tech in deal with Israeli developer SoluBest.
in-PharmaTechnologist presents a round up of cGMP related warning letters issued by the FDA this week.
Johnson & Johnson (J&J) recalls another 128,000 bottles of its over-the-counter painkiller, Tylenol, after new complaints of a “mouldy odour.”
Sanofi Aventis has been given the go ahead to pursue US biotech Genzyme by the country’s antitrust authorities.
The CDMO Althea Technologies has extended its pre-filled syringe manufacturing capabilities with a new INOVA H3-5 high speed syringe filling line, which will be available for production in Q1 2011.
ACS has expanded beyond biopharm BPO services through the acquisition of TMS Health, a provider of support for clinical trials and DTC advertising.
BioClinica is launching its new Trident IVR/IWR platform, to provide a cheaper, quicker way to set up, monitor and maintain randomisation and supplies in clinical trials.
Registrat-Mapi is to advise on the development of Trianz’s electronic and mobile patient reported outcome (ePRO) modules.